Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	54.39	59.82	175.53	20.53	86.51	24.93
Short-Term Investments	240.68	268.31	71	205.91	39	20
Cash & Short-Term Investments	295.06	328.13	246.53	226.44	125.51	44.93
Cash Growth	-20.23%	33.10%	8.87%	80.42%	179.34%	23.96%
Prepaid Expenses	7.9	6.51	4.41	1.25	1.45	1.4
Restricted Cash	-	-	-	-	0.12	-
Total Current Assets	302.97	334.64	250.94	227.69	127.08	46.33
Property, Plant & Equipment	4.83	5.11	0.36	0.95	0.39	0.97
Other Long-Term Assets	2.59	2.61	3.36	2	0.05	0.17
Total Assets	310.39	342.36	254.67	230.63	127.51	47.46
Accounts Payable	3.7	4.32	1.51	0.79	1.56	1.54
Accrued Expenses	12.34	13.43	9.71	7.69	3.28	4.2
Current Portion of Leases	1.39	1.38	0.33	0.58	0.37	0.65
Total Current Liabilities	17.43	19.13	11.55	9.06	5.2	6.39
Long-Term Leases	3.67	3.97	-	0.36	-	0.4
Total Liabilities	21.1	23.1	11.55	9.42	5.2	6.79
Common Stock	0.06	0.06	0.04	0.03	0.01	0
Additional Paid-In Capital	902.35	898.51	728.29	632.51	481.71	301.56
Retained Earnings	-708.5	-674.79	-580.53	-507.64	-455.81	-260.9
Comprehensive Income & Other	0.06	0.16	-	-0.08	-	-
Total Common Equity	193.97	223.94	147.79	124.82	25.91	40.67
Shareholders' Equity	289.29	319.26	243.12	221.22	122.31	40.67
Total Liabilities & Equity	310.39	342.36	254.67	230.63	127.51	47.46
Total Debt	5.06	5.35	0.33	0.94	0.37	1.05
Net Cash (Debt)	290	322.78	246.2	225.5	125.14	43.88
Net Cash Growth	-21.57%	31.10%	9.18%	80.19%	185.17%	29.10%
Net Cash Per Share	5.04	5.75	8.17	15.42	14.02	14.35
Filing Date Shares Outstanding	56.43	56.43	54.9	27.99	13.02	3.9
Total Common Shares Outstanding	56.43	56.43	41.03	27.5	13.02	3.35
Working Capital	285.54	315.51	239.39	218.63	121.87	39.94
Book Value Per Share	3.44	3.97	3.60	4.54	1.99	12.15
Tangible Book Value	193.97	223.94	147.79	124.82	25.91	40.67
Tangible Book Value Per Share	3.44	3.97	3.60	4.54	1.99	12.15

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q